Natural Isothiocyanates Block Adhesion and Invasion of Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines
Molecules · 2026
DOI: 10.3390/molecules31030555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Jochen Rutz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany. Hauptthemen laut MEDLINE: Isothiocyanates, Cisplatin, Drug Resistance, Neoplasm, Deoxycytidine. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Repha GmbH, Langenhagen, Germany, Brigitta & Norbert Muth Stiftung, Wiesbaden, Germany, Brigitte und Dr. Konstanze Wegener-Stiftung, Düsseldorf, Germany.
Abstract (Originalsprache)
Aggressive metastatic progression often develops in bladder cancer patients with acquired cisplatin or gemcitabine resistance. The potential of the natural isothiocyanates allyl-isothiocyanate (AITC), butyl-isothiocyanate (BITC), and phenylethyl-isothiocyanate (PEITC) to inhibit adhesion and migration of cisplatin- or gemcitabine-resistant and sensitive RT112, T24, and TCCSUP bladder cancer cell lines was investigated. Parameters determined were: cell interaction with collagen or fibronectin, chemotaxis, and membrane receptors involved in adhesion (total and activated integrins β1, β4, β5, CD44s, and CD44v3-v7). CD44s’ location and adhesion- and migration-related signaling proteins were determined. AITC blocked adhesion of almost all sensitive and resistant cancer cells. PEITC and BITC suppressed fibronectin interaction of sensitive and resistant RT112. All three isothiocyanates diminished chemotaxis in all cell lines. Integrin expression was differentially altered but CD44s and CD44v were not altered. BITC and PEITC translocated CD44s from the cell membrane to cytoplasm. The tumor suppressor E-cadherin increased, whereas focal adhesion kinase (FAK), linked to integrin signaling, was deactivated after isothiocyanate treatment. Blocking FAK, β1, β4, or β5 was associated with reduced chemotaxis. Thus, AITC, BITC, and PEITC blocked adhesion and migration in cisplatin- and gemcitabine-resistant bladder cancer cells. This was associated with altered integrin expression and signaling, CD44s translocation, and enhanced E-cadherin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology and Pediatric Urology, University Medical Center Mainz, 55131 Mainz, Germany.
- Department of Urology, Goethe-University, 60590 Frankfurt am Main, Germany.
- Institute of Medical Virology, Goethe-University, 60596 Frankfurt am Main, Germany.
- Department of Urology, University Hospital Tübingen, 72076 Tübingen, Germany.
ORCID-Profile: Eva Juengel, Igor Tsaur, Roman A Blaheta
Förderung
- Repha GmbH, Langenhagen, Germany
- Brigitta & Norbert Muth Stiftung, Wiesbaden, Germany
- Brigitte und Dr. Konstanze Wegener-Stiftung, Düsseldorf, Germany
- Dr. Peter und Gabriele Strohmaier-Stiftung, Gütersloh, Germany
Zitieren
APA
Rutz, J., Grein, T., Laqua, M., Benhassine, K., Perktas, E., Cinatl, J., Thomas, A., Chun, F. K., Haferkamp, A., Juengel, E., Tsaur, I., Markowitsch, S. D., & Blaheta, R. A. (2026). Natural Isothiocyanates Block Adhesion and Invasion of Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines. Molecules. https://doi.org/10.3390/molecules31030555
Vancouver
Rutz J, Grein T, Laqua M, Benhassine K, Perktas E, Cinatl J, et al. Natural Isothiocyanates Block Adhesion and Invasion of Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines. Molecules. 2026. doi:10.3390/molecules31030555
BibTeX
@article{Rutz2026,
author = {Rutz, Jochen and Grein, Timothy and Laqua, Marina and Benhassine, Kenza and Perktas, Eren and Cinatl, Jindrich and Thomas, Anita and Chun, Felix K-H and Haferkamp, Axel and Juengel, Eva and Tsaur, Igor and Markowitsch, Sascha D and Blaheta, Roman A},
title = {Natural Isothiocyanates Block Adhesion and Invasion of Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31030555}
}
EUVIMED